Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
Clinical trial NCT03834623 · COMPLETED
Trial details
- NCT number
- NCT03834623
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-14
- Primary completion
- 2021-06-29
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.